載入...
LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21
Imatinib resistance has become a major clinical problem for chronic myeloid leukemia. The aim of the present study was to investigate the involvement of MEG3, a lncRNA, in imatinib resistance and demonstrate its underlying mechanisms. RNAs were extracted from CML patients’ peripheral blood cells and...
Na minha lista:
| 發表在: | Biomol Ther (Seoul) |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Society of Applied Pharmacology
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590792/ https://ncbi.nlm.nih.gov/pubmed/28190319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2016.162 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|